Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy: A Breast International Group (BIG) 1-98 sub-analyses.

被引：0
|
作者：
Leone, Jose Pablo
Cole, Bernard F.
Regan, Meredith M.
Thurlimann, Beat J. K.
Coates, Alan S.
Goldhirsch, Aron
Di Leo, Angelo
Colleoni, Marco
Luis, Ines Maria Vaz Duarte
Lin, Nancy U.
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Univ Vermont, Burlington, VT USA
[3] Dana Farber Harvard Canc Ctr, Beth Israel Deaconess Med Ctr, Boston, MA USA
[4] Kantonsspital, St Gallen, Switzerland
[5] Univ Sydney, Sydney, NSW, Australia
[6] IBCSG Investigator, Bern, Switzerland
[7] SOLE Investigator, Bern, Switzerland
[8] Hosp Prato, Prato, Italy
[9] European Inst Oncol, Milan, Italy
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.538
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
538
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
    Dieter Koeberle
    Beat Thuerlimann
    Breast Cancer Research and Treatment, 2008, 112 (2) : 387 - 387
  • [22] Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
    Dieter Koeberle
    Beat Thuerlimann
    Breast Cancer Research and Treatment, 2007, 105 : 55 - 66
  • [23] Letrozole as upfront endocrine therapy for postmenopausal women with hormone-sensitive breast cancer: BIG 1-98
    Koeberle, Dieter
    Thuerlimann, Beat
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 105 (Suppl 1) : 55 - 66
  • [24] The Optimal Duration of Endocrine Therapy in Hormone Receptor-Positive Breast Cancer
    Sledge, George W., Jr.
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (06) : 383 - 404
  • [25] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Sharvina Ziyeh
    Lauren Wong
    Reva K. Basho
    Current Oncology Reports, 2023, 25 : 689 - 698
  • [26] Advances in Endocrine Therapy for Hormone Receptor-Positive Advanced Breast Cancer
    Ziyeh, Sharvina
    Wong, Lauren
    Basho, Reva K.
    CURRENT ONCOLOGY REPORTS, 2023, 25 (07) : 689 - 698
  • [27] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update
    Burstein, Harold J.
    Lacchetti, Christina
    Griggs, Jennifer J.
    JOURNAL OF ONCOLOGY PRACTICE, 2019, 15 (02) : 106 - +
  • [28] Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update
    Burstein, Harold J.
    Lacchetti, Christina
    Anderson, Holly
    Buchholz, Thomas A.
    Davidson, Nancy E.
    Gelmon, Karen A.
    Giordano, Sharon H.
    Hudis, Clifford A.
    Solky, Alexander J.
    Stearns, Vered
    Winer, Eric P.
    Griggs, Jennifer J.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (05) : 423 - +
  • [29] Predictors of early recurrence in postmenopausal women with hormone receptor positive breast cancer in the BIG 1-98 trial
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 111 - 111
  • [30] Central assessment of ER, PgR and HER2 in BIG 1-98 evaluating letrozole (L) compared to tamoxifen (T) as initial adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive breast cancer
    Rasmussen, B. B.
    Regan, M. M.
    Lykkesfeldt, A. E.
    Dell'Orto, P.
    Del Curto, B.
    Henriksen, K. L.
    Mastropasqua, M. G.
    Thurlimann, B.
    Viale, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345